Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma.
Cerebellar glioblastoma
Neuro-oncology
Neurosurgery
Onco-functional outcome
Survival analysis
Journal
Journal of cancer research and clinical oncology
ISSN: 1432-1335
Titre abrégé: J Cancer Res Clin Oncol
Pays: Germany
ID NLM: 7902060
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
16
09
2020
accepted:
18
11
2020
pubmed:
6
1
2021
medline:
26
5
2021
entrez:
5
1
2021
Statut:
ppublish
Résumé
To analyze the outcomes and predictors in a large series of cerebellar glioblastomas in order to guide patient management. The French brain tumor database and the Club de Neuro-Oncologie of the Société Française de Neurochirurgie retrospectively identified adult patients with cerebellar glioblastoma diagnosed between 2003 and 2017. Diagnosis was confirmed by a centralized neuropathological review. Data from 118 cerebellar glioblastoma patients were analyzed (mean age 55.9 years, 55.1% males). The clinical presentation associated raised intracranial pressure (50.8%), static cerebellar syndrome (68.6%), kinetic cerebellar syndrome (49.2%) and/or cranial nerve disorders (17.8%). Glioblastomas were hemispheric (55.9%), vermian (14.4%) or both (29.7%). Hydrocephalus was present in 49 patients (41.5%). Histologically, tumors corresponded either to IDH-wild-type or to K27-mutant glioblastomas. Surgery consisted of total (12.7%), subtotal (35.6%), partial resection (33.9%) or biopsy (17.8%). The postoperative Karnofsky performance status was improved, stable and worsened in 22.4%, 43.9% and 33.7% of patients, respectively. Progression-free and overall survivals reached 5.1 months and 9.1 months, respectively. Compared to other surgical strategies, total or subtotal resection improved the Karnofsky performance status (33.3% vs 12.5%, p < 0.001), prolonged progression-free and overall survivals (6.5 vs 4.3 months, p = 0.015 and 16.7 vs 6.2 months, p < 0.001, respectively) and had a comparable complication rate (40.4% vs 31.1%, p = 0.29). After total or subtotal resection, the functional outcomes were correlated with age (p = 0.004) and cerebellar hemispheric tumor location (p < 0.001) but not brainstem infiltration (p = 0.16). In selected patients, maximal resection of cerebellar glioblastoma is associated with improved onco-functional outcomes, compared with less invasive procedures.
Identifiants
pubmed: 33399987
doi: 10.1007/s00432-020-03474-6
pii: 10.1007/s00432-020-03474-6
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1843-1856Investigateurs
Fabienne Bauchet
(F)
Rim Ben Mhamed
(RB)
Faiza Bessaoud
(F)
Valérie Rigau
(V)
Hélène Mathieu-Daudé
(H)
Amélie Darlix
(A)
Pascale Fabbro-Peray
(P)
Brigitte Trétarre
(B)
Hugues Loiseau
(H)
Jean-Rodolphe Vignes
(JR)
Mathilde Guibourd de Luzinais
(MG)
Matthieu Peyre
(M)
Eric Bord
(E)
Edouard Samarut
(E)
Romuald Seizeur
(R)
Walid Farah
(W)
Anne Herbrecht
(A)
Nicolas Reyns
(N)
Jimmy Voirin
(J)
Hélène Cebula
(H)
Evelyne Emery
(E)
Adrien Simonneau
(A)
Philippe Caillaud
(P)
Philippe Menei
(P)
Gwénaëlle Soulard
(G)
Bertrand Muckensturm
(B)
Fabien Rech
(F)
Fabien Almairac
(F)
Marie Onno
(M)
Marine Lecorre
(M)
Arnaud Dagain
(A)
François Vassal
(F)
Benjamin Pommier
(B)
Emmanuel Gay
(E)
Emmanuel De Schlichting
(E)
Hassan El-Fertit
(H)
André Maillard
(A)
Emmanuel Mandonnet
(E)
Thibault Passeri
(T)
Jean-Jacques Lemaire
(JJ)
Rémy Chaix
(R)
Mathilde Fouet
(M)
Jean-Christophe Sol
(JC)
Imène Djidjelli
(I)
Stéphane Gaillard
(S)
Olivier Langlois
(O)
François-Xavier Ferracci
(FX)
Henri Dufour
(H)
Pierre-Hugues Roche
(PH)
Sébastien Boissonneau
(S)
Christine Desenclos
(C)
Thierry Faillot
(T)
Ilyess Zemmoura
(I)
Pierre-Jean Le Reste
(PJ)
Références
Adams H, Chaichana KL, Avendaño J et al (2013) Adult cerebellar glioblastoma: understanding survival and prognostic factors using a population-based database from 1973 to 2009. World Neurosurg 80:e237-243. https://doi.org/10.1016/j.wneu.2013.02.010
doi: 10.1016/j.wneu.2013.02.010
pubmed: 23395851
pmcid: 3994535
Akimoto J, Fukami S, Tsutsumi M et al (2009) Radiopathological characteristics of cerebellar malignant glioma in adults. Brain Tumor Pathol 26:59–68. https://doi.org/10.1007/s10014-009-0248-x
doi: 10.1007/s10014-009-0248-x
pubmed: 19856216
Albert FK, Forsting M, Sartor K et al (1994) Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34:45–60 ((discussion 60-61))
pubmed: 8121569
Audureau E, Chivet A, Ursu R et al (2018) Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model. J Neurooncol 136:565–576. https://doi.org/10.1007/s11060-017-2685-4
doi: 10.1007/s11060-017-2685-4
pubmed: 29159777
Babu R, Sharma R, Karikari IO et al (2013) Outcome and prognostic factors in adult cerebellar glioblastoma. J Clin Neurosci 20:1117–1121. https://doi.org/10.1016/j.jocn.2012.12.006
doi: 10.1016/j.jocn.2012.12.006
pubmed: 23706183
Carson KA, Grossman SA, Fisher JD, Shaw EG (2007) Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials. J Clin Oncol 25:2601–2606. https://doi.org/10.1200/JCO.2006.08.1661
doi: 10.1200/JCO.2006.08.1661
pubmed: 17577040
pmcid: 4118746
Chaichana KL, Cabrera-Aldana EE, Jusue-Torres I et al (2014) When gross total resection of a glioblastoma is possible, how much resection should be achieved? World Neurosurg 82:e257-265. https://doi.org/10.1016/j.wneu.2014.01.019
doi: 10.1016/j.wneu.2014.01.019
pubmed: 24508595
Chamberlain MC, Silver P, Levin VA (1990) Poorly differentiated gliomas of the cerebellum. A study of 18 patients. Cancer 65:337–340. https://doi.org/10.1002/1097-0142(19900115)65:2%3c337::aid-cncr2820650226%3e3.0.co;2-p
doi: 10.1002/1097-0142(19900115)65:2<337::aid-cncr2820650226>3.0.co;2-p
pubmed: 2295056
Cho HJ, Zhao J, Jung SW et al (2019) Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma. Neuro-oncology 21:47–58. https://doi.org/10.1093/neuonc/noy123
doi: 10.1093/neuonc/noy123
pubmed: 30085274
Darlix A, Zouaoui S, Rigau V et al (2017) Epidemiology for primary brain tumors: a nationwide population-based study. J Neurooncol 131:525–546. https://doi.org/10.1007/s11060-016-2318-3
doi: 10.1007/s11060-016-2318-3
pubmed: 27853959
Djalilian HR, Hall WA (1998) Malignant gliomas of the cerebellum: an analytic review. J Neurooncol 36:247–257
doi: 10.1023/A:1005704006244
Dressler EV, Liu M, Garcia CR et al (2019) Patterns and disparities of care in glioblastoma. Neurooncol Pract 6:37–46. https://doi.org/10.1093/nop/npy014
doi: 10.1093/nop/npy014
pubmed: 30740232
Duffau H (2009) Surgery of low-grade gliomas: towards a “functional neurooncology.” Curr Opin Oncol 21:543–549. https://doi.org/10.1097/CCO.0b013e3283305996
doi: 10.1097/CCO.0b013e3283305996
pubmed: 19606033
Fabbro-Peray P, Zouaoui S, Darlix A et al (2019) Association of patterns of care, prognostic factors, and use of radiotherapy-temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study. J Neurooncol 142:91–101. https://doi.org/10.1007/s11060-018-03065-z
doi: 10.1007/s11060-018-03065-z
pubmed: 30523606
Flower H, Gallo P (2019) Cerebellar glioblastoma in an NF1 patient. Is it surgical debulking really necessary? Br J Neurosurg. https://doi.org/10.1080/02688697.2019.1690127
doi: 10.1080/02688697.2019.1690127
pubmed: 31746226
Gopalakrishnan CV, Dhakoji A, Nair S et al (2012) A retrospective study of primary cerebellar glioblastoma multiforme in adults. J Clin Neurosci 19:1684–1688. https://doi.org/10.1016/j.jocn.2011.12.035
doi: 10.1016/j.jocn.2011.12.035
pubmed: 23084346
Hong B, Banan R, Christians A et al (2018) Cerebellar glioblastoma: a clinical series with contemporary molecular analysis. Acta Neurochir (Wien) 160:2237–2248. https://doi.org/10.1007/s00701-018-3673-y
doi: 10.1007/s00701-018-3673-y
Ilg W, Giese MA, Gizewski ER et al (2008) The influence of focal cerebellar lesions on the control and adaptation of gait. Brain 131:2913–2927. https://doi.org/10.1093/brain/awn246
doi: 10.1093/brain/awn246
pubmed: 18835866
Jeswani S, Nuño M, Folkerts V et al (2013) Comparison of survival between cerebellar and supratentorial glioblastoma patients: surveillance, epidemiology, and end results (SEER) analysis. Neurosurgery 73:240–246. https://doi.org/10.1227/01.neu.0000430288.85680.37 ((discussion 246; quiz 246))
doi: 10.1227/01.neu.0000430288.85680.37
pubmed: 23615082
Konczak J, Schoch B, Dimitrova A et al (2005) Functional recovery of children and adolescents after cerebellar tumour resection. Brain 128:1428–1441. https://doi.org/10.1093/brain/awh385
doi: 10.1093/brain/awh385
pubmed: 15659424
Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198. https://doi.org/10.3171/jns.2001.95.2.0190
doi: 10.3171/jns.2001.95.2.0190
pubmed: 11780887
Lakičević G, Arnautović K, Mužević D, Chesney T (2014) Cerebellar glioblastoma multiforme presenting as hypertensive cerebellar hemorrhage: case report. J Neurol Surg Rep 75:e117-121. https://doi.org/10.1055/s-0034-1376198
doi: 10.1055/s-0034-1376198
pubmed: 25097829
pmcid: 4110145
Li YM, Suki D, Hess K, Sawaya R (2016) The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection? J Neurosurg 124:977–988. https://doi.org/10.3171/2015.5.JNS142087
doi: 10.3171/2015.5.JNS142087
pubmed: 26495941
Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1
doi: 10.1007/s00401-016-1545-1
pubmed: 27157931
pmcid: 27157931
Mandel JJ, Yust-Katz S, Cachia D et al (2014) Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution. J Neurooncol 120:597–605. https://doi.org/10.1007/s11060-014-1592-1
doi: 10.1007/s11060-014-1592-1
pubmed: 25168214
Molinaro AM, Hervey-Jumper S, Morshed RA et al (2020) Association of maximal extent of resection of contrast-enhanced and non-contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed glioblastoma. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2019.6143
doi: 10.1001/jamaoncol.2019.6143
pubmed: 32027343
pmcid: 7042822
Nakata S, Nobusawa S, Yamazaki T et al (2017) Histone H3 K27M mutations in adult cerebellar high-grade gliomas. Brain Tumor Pathol 34:113–119. https://doi.org/10.1007/s10014-017-0288-6
doi: 10.1007/s10014-017-0288-6
pubmed: 28547652
Ng S, Zouaoui S, Bessaoud F et al (2019) An epidemiology report for primary central nervous system tumors in adolescents and young adults: a nationwide population-based study in France, 2008–2013. Neuro-oncology. https://doi.org/10.1093/neuonc/noz227
doi: 10.1093/neuonc/noz227
pubmed: 31158293
pmcid: 6847952
Nomura M, Mukasa A, Nagae G et al (2017) Distinct molecular profile of diffuse cerebellar gliomas. Acta Neuropathol 134:941–956. https://doi.org/10.1007/s00401-017-1771-1
doi: 10.1007/s00401-017-1771-1
pubmed: 28852847
pmcid: 5663812
Patil CG, Eboli P, Hu J (2012) Management of multifocal and multicentric gliomas. Neurosurg Clin N Am 23(343–350):x. https://doi.org/10.1016/j.nec.2012.01.012
doi: 10.1016/j.nec.2012.01.012
Picart T, Barritault M, Berthillier J et al (2018) Characteristics of cerebellar glioblastomas in adults. J Neurooncol 136:555–563. https://doi.org/10.1007/s11060-017-2682-7
doi: 10.1007/s11060-017-2682-7
pubmed: 29196927
Picart T, Berhouma M, Dumot C et al (2019) Optimization of high-grade glioma resection using 5-ALA fluorescence-guided surgery: a literature review and practical recommendations from the neuro-oncology club of the French society of neurosurgery. Neurochirurgie. https://doi.org/10.1016/j.neuchi.2019.04.005
doi: 10.1016/j.neuchi.2019.04.005
pubmed: 31125558
Picart T, Le Corre M, Chan-Seng E et al (2018) The enigma of multicentric glioblastoma: physiopathogenic hypothesis and discussion about two cases. Br J Neurosurg 32:610–613. https://doi.org/10.1080/02688697.2018.1501465
doi: 10.1080/02688697.2018.1501465
pubmed: 30136593
Porter JM, Pidgeon C, Cunningham AJ (1999) The sitting position in neurosurgery: a critical appraisal. Br J Anaesth 82:117–128
doi: 10.1093/bja/82.1.117
Reinhardt A, Stichel D, Schrimpf D et al (2019) Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities. Acta Neuropathol Commun 7:163. https://doi.org/10.1186/s40478-019-0801-8
doi: 10.1186/s40478-019-0801-8
pubmed: 31661039
pmcid: 6816155
Rigau V, Zouaoui S, Mathieu-Daudé H et al (2011) French brain tumor database: 5-year histological results on 25 756 cases. Brain Pathol 21:633–644. https://doi.org/10.1111/j.1750-3639.2011.00491.x
doi: 10.1111/j.1750-3639.2011.00491.x
pubmed: 21554472
Salvati M, Caroli E, Orlando ER et al (2003) Multicentric glioma: our experience in 25 patients and critical review of the literature. Neurosurg Rev 26:275–279. https://doi.org/10.1007/s10143-003-0276-7
doi: 10.1007/s10143-003-0276-7
pubmed: 12898393
Sanai N, Polley M-Y, McDermott MW et al (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115:3–8. https://doi.org/10.3171/2011.7.JNS10238
doi: 10.3171/2011.7.JNS10238
pubmed: 21417701
Schoch B, Hogan A, Gizewski ER et al (2010) Balance control in sitting and standing in children and young adults with benign cerebellar tumors. Cerebellum 9:324–335. https://doi.org/10.1007/s12311-010-0165-x
doi: 10.1007/s12311-010-0165-x
pubmed: 20352395
Singla N, Kapoor A, Savardekar A et al (2016) Malignant cerebellar peduncle lesions—rapid progression and poor outcome. Surg Neurol Int 7:S170-173. https://doi.org/10.4103/2152-7806.178569
doi: 10.4103/2152-7806.178569
pubmed: 27057396
pmcid: 4804400
Sreenivasan SA, Madhugiri VS, Sasidharan GM, Kumar RVR (2016) Measuring glioma volumes: a comparison of linear measurement based formulae with the manual image segmentation technique. J Cancer Res Ther 12:161–168. https://doi.org/10.4103/0973-1482.153999
doi: 10.4103/0973-1482.153999
pubmed: 27072231
Srinivasan VM, Ghali MGZ, North RY et al (2016) Modern management of medulloblastoma: molecular classification, outcomes, and the role of surgery. Surg Neurol Int 7:S1135–S1141. https://doi.org/10.4103/2152-7806.196922
doi: 10.4103/2152-7806.196922
pubmed: 28194300
pmcid: 5299153
Stark AM, Maslehaty H, Hugo HH et al (2010) Glioblastoma of the cerebellum and brainstem. J Clin Neurosci 17:1248–1251. https://doi.org/10.1016/j.jocn.2010.02.015
doi: 10.1016/j.jocn.2010.02.015
pubmed: 20619657
Takahashi Y, Makino K, Nakamura H et al (2014) Clinical characteristics and pathogenesis of cerebellar glioblastoma. Mol Med Rep 10:2383–2388. https://doi.org/10.3892/mmr.2014.2549
doi: 10.3892/mmr.2014.2549
pubmed: 25199771
Tauziède-Espariat A, Saffroy R, Pagès M et al (2018) Cerebellar high-grade gliomas do not present the same molecular alterations as supratentorial high-grade gliomas and may show histone H3 gene mutations. Clin Neuropathol 37:209–216. https://doi.org/10.5414/NP301104
doi: 10.5414/NP301104
pubmed: 29809131
Tsung AJ, Prabhu SS, Lei X et al (2011) Cerebellar glioblastoma: a retrospective review of 21 patients at a single institution. J Neurooncol 105:555–562. https://doi.org/10.1007/s11060-011-0617-2
doi: 10.1007/s11060-011-0617-2
pubmed: 21643841
Weber DC, Miller RC, Villà S et al (2006) Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network. Int J Radiat Oncol Biol Phys 66:179–186. https://doi.org/10.1016/j.ijrobp.2006.04.035
doi: 10.1016/j.ijrobp.2006.04.035
pubmed: 16814953
Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972. https://doi.org/10.1200/JCO.2009.26.3541
doi: 10.1200/JCO.2009.26.3541
pubmed: 20231676
Wong T-T, Liu Y-L, Ho DM-T et al (2015) Factors affecting survival of medulloblastoma in children: the changing concept of management. Childs Nerv Syst 31:1687–1698. https://doi.org/10.1007/s00381-015-2884-2
doi: 10.1007/s00381-015-2884-2
pubmed: 26351222
Wu J, Armstrong TS, Gilbert MR (2016) Biology and management of ependymomas. Neuro Oncol 18:902–913. https://doi.org/10.1093/neuonc/now016
doi: 10.1093/neuonc/now016
pubmed: 27022130
pmcid: 4896548
Yang S, Liu J, Wang T et al (2013) Cerebellar glioblastoma multiforme: a retrospective study of 28 patients at a single institution. Int J Neurosci 123:691–697. https://doi.org/10.3109/00207454.2013.791292
doi: 10.3109/00207454.2013.791292
pubmed: 23550813
Zouaoui S, Rigau V, Mathieu-Daudé H et al (2012) French brain tumor database: general results on 40,000 cases, main current applications and future prospects. Neurochirurgie 58:4–13. https://doi.org/10.1016/j.neuchi.2012.01.004
doi: 10.1016/j.neuchi.2012.01.004
pubmed: 22385800